시장보고서
상품코드
1838717

반려동물 골관절염 시장 : 시장 분석 및 예측 - 유형별, 제품별, 서비스별, 기술별, 용도별, 최종 사용자별, 디바이스별, 컴포넌트별, 솔루션별(-2034년)

Companion Animal Osteoarthritis Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Device, Component, Solutions

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 335 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

반려동물 골관절염 시장은 2024년 23억 달러에서 2034년에는 185억 달러로 확대될 전망이며, 약 23%의 연평균 복합 성장률(CAGR)로 성장할 것으로 예측됩니다. 반려동물 골관절염 시장은 반려동물, 특히 개와 고양이의 골관절염의 치료와 개입을 다룹니다. 여기에는 관절통 완화와 운동 능력 향상을 목적으로 하는 의약품, 영양 보충제, 치료법이 포함됩니다. 반려동물의 사육두수 증가와 동물의 복지에 대한 의식의 고조가 시장 성장의 원동력이 되고 있습니다. 생물 제제 및 재생 치료의 혁신은 치료 효과 및 반려동물 삶의 질을 향상시키는 유망한 수단을 제공합니다.

반려동물 골관절염 시장은 반려동물 사육 증가와 동물 건강에 대한 인식 증가에 힘입어 강력한 확장을 경험하고 있습니다. 의약품 분야는 최전선에 있으며, 비스테로이드성 항염증제(NSAIDs)는 통증 관리에 효과적이므로 하위 부문에서 최고 실적을 올리고 있습니다. 질병 개질성 골관절염 치료제(DMOADs)는 치료 옵션의 진보를 반영하여 2위의 하위 부문으로서 기세를 늘리고 있습니다. 영양보조식품(Nutraceuticals) 분야는 또한 예방책을 요구하는 주인들 사이에서 관절의 건강 보충제가 인기를 끌고 있다는 배경으로 큰 성장을 보여줍니다. 이 부문에서는 글루코사민과 콘드로이틴 보충제가 선도하고 있으며, 항염증 작용이 인정되고 있는 오메가 3 지방산이 이어지고 있습니다. 수의학 서비스 부문은 확대되고 있으며, 재활과 물리치료 서비스가 종합적인 골관절염 관리의 중요한 요소로 부상하고 있습니다. 고급 진단 도구와 맞춤 치료 계획의 통합으로 시장 기회가 더욱 확대되고 있으며, 이러한 진화 상황에서 기술 혁신의 중요성이 부각되고 있습니다.

시장 세분화
유형별 의약품, 생물제제, 영양보조식품, 의료기기, 치료제, 진단약, 예방약, 재활약
제품별 비스테로이드성 항염증제(NSAIDs), 질환 변형성 변형성 관절증 치료제(DMOADs), 진통제, 관절 보충제, 관절내 주사, 국소 치료제
서비스별 동물 병원, 동물 클리닉, 홈 케어 서비스, 원격 의료, 재활센터, 컨설테이션 서비스, 진단 서비스
기술별 유전자 치료, 줄기 세포 치료, 재생 의료, 생명공학, 파마코유전체학, 나노기술
용도별 통증 관리, 염증 경감, 연골 복구, 운동 능력 향상, QOL 향상
최종 사용자별 수의학 관계자, 반려동물 소유자, 연구 기관, 제약 회사, 학술 기관
디바이스별 정형외과용 임플란트, 인공관절, 이동 보조기구, 웨어러블 디바이스, 모니터링 디바이스
컴포넌트별 의약품 활성 성분, 부형제, 생물학적 제제 성분, 영양 보조 식품 성분, 장비 부품
솔루션별 통합 케어 솔루션, 맞춤형 의료 솔루션, 데이터 분석 솔루션

시장 현황

반려동물 골관절염 시장은 주요 기업 간 다양한 시장 점유율 분포를 특징으로 하는 역동적인 변화를 목격하고 있습니다. 가격 전략은 진화하고 있으며 각 회사는 광범위한 고객층을 얻기 위해 경쟁 가격을 채택하고 있습니다. 신제품 출시는 빈번히 진행되고 있으며, 미충족 요구에 대응하기 위한 혁신적인 치료법과 치료 방법에 초점이 맞추어져 있습니다. 이 동향은 반려동물 주인의 의식 증가 및 동물 의료의 진보에 추진되고 있습니다. 또한 홀리스틱한 치료법을 요구하는 소비자의 기호를 반영하여 천연 소재와 유기농 제품에 대한 수요도 높아지고 있습니다. 경쟁 벤치마킹에서는 소수의 대기업이 우위를 차지하는 상황이 밝혀졌지만, 지역 기업은 틈새 제품을 제공함으로써 견인력을 늘리고 있습니다. 규제의 영향은 크며 제품 승인과 안전 기준을 관리하는 엄격한 정책이 있습니다. 이러한 규제는 고품질의 제품을 보장하지만 시장 진입의 과제가 되고 있습니다. 시장은 또한 반려동물 사육률 증가와 반려동물 수명 증가와 같은 인구 통계학적 요인의 영향을 받고 있으며, 이는 골관절염 치료제 수요를 촉진하고 있습니다.

주요 동향 및 성장 촉진요인 :

반려동물 골관절염 시장은 반려동물 사육률 증가 및 반려동물 건강에 대한 의식이 높아짐에 따라 강력한 성장을 이루고 있습니다. 반려동물의 인간화는 주인의 선진 치료에 대한 투자 의욕 증가로 이어지고 있습니다. 이 추세는 혁신적인 치료법과 통증 관리 솔루션에 대한 수요를 촉진합니다. 재생 의료 및 생물 제제와 같은 기술의 진보는 치료 옵션을 바꾸고 있습니다. 이러한 혁신은 효과와 안전성 프로파일을 향상시키고 수의사와 주인 모두에게 호소합니다. 또한, 반려동물의 비만 증가가 골관절염의 발병에 기여하고 시장 수요를 밀어올리고 있습니다. 조기 진단 및 맞춤 치료 계획 등 동물 의료 진보가 질병 관리를 강화하고 있습니다. 신흥 시장에서 수의학 서비스의 확대는 유리한 기회를 제공합니다. 게다가 반려동물의 보험 가입이 가능해지고 있는 것도 주인이 종합적인 치료 옵션을 요구하는 것을 뒷받침하고 있습니다. 이러한 진화하는 시장 상황은 시장의 지속적인 성장과 혁신으로 이어집니다.

성장 억제요인 및 과제 :

반려동물 골관절염 시장에는 몇 가지 중요한 억제요인 및 과제가 있습니다. 주요 장애물은 혁신적인 치료법의 비용이 높다는 것입니다. 이 경제적 부담은 반려동물 주인들 사이에서 널리 채택되는 것을 방해합니다. 또, 시판약에 의지하고 있는 주인도 많습니다. 또한, 반려동물의 골관절염 증상에 대한 인식이 부족하여 진단과 치료가 지연되고 있습니다. 수의사 전문가들은 다른 질병과 증상이 중복되기 때문에 골관절염을 정확하게 진단하는 데 어려움을 겪고 있습니다. 이러한 복잡성은 오진증이나 과소 진단으로 이어질 수 있습니다. 또한, 반려동물의 보험 적용 범위가 제한되어 고급 치료에 대한 액세스가 제한됩니다. 주인이 전체 비용을 부담하는 경우도 많아, 법외의 부담이 되는 경우도 있습니다. 마지막으로 새로운 치료를 승인하는 규제 장애물은 시장 진입을 늦추고 기술 혁신을 방해할 수 있습니다. 이러한 요인은 반려동물에 대한 효과적인 골관절염 치료의 성장과 사용 편의성을 억제합니다.

주요 기업

Vetoquinol, Dechra Pharmaceuticals, Virbac, Elanco Animal Health, Zoetis, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Bayer Animal Health, Merial, Norbrook Laboratories, Orion Pharma, Aratana Therapeutics, Chanel Pharma, Phibro Animal Health, Animalcare Group

목차

제1장 반려동물 골관절염 시장 개요

  • 조사 목적
  • 반려동물 골관절염 시장 정의 및 조사 범위
  • 보고서 제한
  • 조사 대상 연도 및 통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 중요 인사이트

제4장 반려동물 골관절염 시장 전망

  • 반려동물 골관절염 시장의 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 반려동물 골관절염 시장 전략

  • 상위 시장 분석
  • 수급 분석
  • 소비자의 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 반려동물 골관절염 시장 규모

  • 반려동물 골관절염 시장 규모 : 금액별
  • 반려동물 골관절염 시장 규모 : 수량별

제7장 반려동물 골관절염 시장 : 유형별

  • 시장 개요
  • 의약품
  • 생물제제
  • 영양보조식품
  • 의료기기
  • 치료제
  • 진단약
  • 예방
  • 재활
  • 기타

제8장 반려동물 골관절염 시장 : 제품별

  • 시장 개요
  • 비스테로이드성 항염증제(NSAIDs)
  • 질환 수식성 변형성 관절증 치료제(DMOADs)
  • 진통제
  • 관절용 보충제
  • 관절내 주사
  • 국소 치료
  • 기타

제9장 반려동물 골관절염 시장 : 서비스별

  • 시장 개요
  • 수의 클리닉
  • 동물병원
  • 재택 케어 서비스
  • 원격 의료
  • 재활센터
  • 상담 서비스
  • 진단 서비스
  • 기타

제10장 반려동물 골관절염 시장 : 기술별

  • 시장 개요
  • 유전자 치료
  • 줄기세포 요법
  • 재생 의료
  • 생명공학
  • 파마코유전체학
  • 나노기술
  • 기타

제11장 반려동물 골관절염 시장 : 용도별

  • 시장 개요
  • 통증 관리
  • 염증 경감
  • 연골 복구
  • 운동 능력 향상
  • 생활의 질 향상
  • 기타

제12장 반려동물 골관절염 시장 : 최종 사용자별

  • 시장 개요
  • 수의 전문가
  • 반려동물 소유자
  • 연구기관
  • 제약회사
  • 학술기관
  • 기타

제13장 반려동물 골관절염 시장 : 디바이스별

  • 시장 개요
  • 정형외과 임플란트
  • 보장구
  • 이동 보조기구
  • 웨어러블 디바이스
  • 모니터링 기기
  • 기타

제14장 반려동물 골관절염 시장 : 컴포넌트별

  • 시장 개요
  • 원약
  • 부형제
  • 생물학적 성분
  • 영양 보조 식품 성분
  • 디바이스 성분
  • 기타

제15장 반려동물 골관절염 시장 : 솔루션별

  • 시장 개요
  • 통합 케어 솔루션
  • 맞춤형 의료 솔루션
  • 데이터 분석 솔루션
  • 기타

제16장 반려동물 골관절염 시장 : 지역별

  • 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 남아프리카
    • 기타 중동 및 아프리카

제17장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략의 벤치마킹

제18장 기업 프로파일

  • Vetoquinol
  • Dechra Pharmaceuticals
  • Virbac
  • Elanco Animal Health
  • Zoetis
  • Boehringer Ingelheim Animal Health
  • Ceva Sante Animale
  • Bayer Animal Health
  • Merial
  • Norbrook Laboratories
  • Orion Pharma
  • Aratana Therapeutics
  • Chanelle Pharma
  • Phibro Animal Health
  • Animalcare Group
AJY

Companion Animal Osteoarthritis Market is anticipated to expand from $2.3 billion in 2024 to $18.5 billion by 2034, growing at a CAGR of approximately 23%. The Companion Animal Osteoarthritis Market encompasses treatments and interventions for osteoarthritis in pets, particularly dogs and cats. This includes pharmaceuticals, nutraceuticals, and therapeutic modalities aimed at alleviating joint pain and improving mobility. Rising pet ownership and increasing awareness of animal well-being drive market growth. Innovations in biologics and regenerative therapies offer promising avenues for enhanced treatment efficacy and pet quality of life.

The Companion Animal Osteoarthritis Market is experiencing robust expansion, propelled by increasing pet ownership and heightened awareness of animal health. The pharmaceutical segment is at the forefront, with non-steroidal anti-inflammatory drugs (NSAIDs) being the top-performing sub-segment due to their efficacy in pain management. Disease-modifying osteoarthritis drugs (DMOADs) are gaining momentum as the second-highest performing sub-segment, reflecting advancements in therapeutic options. The nutraceuticals segment is also witnessing significant growth, driven by the popularity of joint health supplements among pet owners seeking preventive measures. Within this segment, glucosamine and chondroitin supplements lead, followed by omega-3 fatty acids, which are increasingly recognized for their anti-inflammatory properties. The veterinary care services segment is expanding, with rehabilitation and physical therapy services emerging as critical components of comprehensive osteoarthritis management. The integration of advanced diagnostic tools and personalized treatment plans is further enhancing market opportunities, underscoring the importance of innovation in this evolving landscape.

Market Segmentation
TypePharmaceuticals, Biologics, Nutraceuticals, Medical Devices, Therapeutics, Diagnostics, Preventive, Rehabilitative
ProductNon-steroidal Anti-inflammatory Drugs (NSAIDs), Disease Modifying Osteoarthritis Drugs (DMOADs), Analgesics, Joint Supplements, Intra-articular Injections, Topical Treatments
ServicesVeterinary Clinics, Animal Hospitals, Home Care Services, Telemedicine, Rehabilitation Centers, Consultation Services, Diagnostic Services
TechnologyGene Therapy, Stem Cell Therapy, Regenerative Medicine, Biotechnology, Pharmacogenomics, Nanotechnology
ApplicationPain Management, Inflammation Reduction, Cartilage Repair, Mobility Improvement, Quality of Life Enhancement
End UserVeterinary Professionals, Pet Owners, Research Institutions, Pharmaceutical Companies, Academic Institutes
DeviceOrthopedic Implants, Prosthetics, Mobility Aids, Wearable Devices, Monitoring Devices
ComponentActive Pharmaceutical Ingredients, Excipients, Biologic Components, Nutraceutical Ingredients, Device Components
SolutionsIntegrated Care Solutions, Personalized Medicine Solutions, Data Analytics Solutions

Market Snapshot:

The Companion Animal Osteoarthritis Market is witnessing a dynamic shift, characterized by diverse market share distribution among key players. Pricing strategies are evolving, with companies adopting competitive pricing to capture a broader customer base. New product launches are frequent, focusing on innovative therapies and treatment modalities to address unmet needs. This trend is driven by increasing awareness among pet owners and advancements in veterinary medicine. The market is also seeing a rise in demand for natural and organic products, reflecting consumer preferences for holistic treatment options. Competition benchmarking reveals a landscape dominated by a few large players, yet regional companies are gaining traction through niche offerings. Regulatory influences are significant, with stringent policies governing product approvals and safety standards. These regulations ensure high-quality products but pose challenges for market entry. The market is further influenced by demographic factors, such as the rising pet ownership rates and increasing life expectancy of companion animals, which drive demand for osteoarthritis treatments.

Geographical Overview:

The Companion Animal Osteoarthritis Market is witnessing varied growth across regions, each presenting unique opportunities. North America leads the charge, driven by a high awareness of pet healthcare and robust veterinary infrastructure. The demand for innovative therapies and treatments is propelling market expansion. Europe follows, where a strong emphasis on animal welfare and advanced veterinary practices supports market growth. In Asia Pacific, the market is burgeoning, fueled by rising pet ownership and increasing disposable incomes. Countries like China and India are emerging as lucrative markets, with a growing middle class investing in pet healthcare. Latin America shows potential, with Brazil and Mexico spearheading growth due to an increasing focus on companion animal health. The Middle East & Africa are also emerging, recognizing the importance of veterinary care in enhancing the quality of life for pets. These regions are gradually adopting advanced treatments, opening new avenues for market players.

Key Trends and Drivers:

The Companion Animal Osteoarthritis Market is experiencing robust growth due to rising pet ownership and increasing awareness of pet health. The humanization of pets is leading to a greater willingness among owners to invest in advanced treatments. This trend is driving demand for innovative therapies and pain management solutions. Technological advancements, such as regenerative medicine and biologics, are transforming treatment options. These innovations offer improved efficacy and safety profiles, appealing to both veterinarians and pet owners. Furthermore, the growing prevalence of obesity in pets is contributing to osteoarthritis incidence, thus boosting market demand. Veterinary care advancements, including early diagnostics and personalized treatment plans, are enhancing disease management. The expansion of veterinary services in emerging markets presents lucrative opportunities. Additionally, the increasing availability of insurance coverage for pets is encouraging owners to seek comprehensive treatment options. This evolving landscape positions the market for sustained growth and innovation.

Restraints and Challenges:

The Companion Animal Osteoarthritis Market encounters several significant restraints and challenges. A primary obstacle is the high cost of innovative treatments. This financial burden inhibits widespread adoption among pet owners. Many individuals still depend on over-the-counter medications, which may offer limited relief. Additionally, there is a lack of awareness regarding osteoarthritis symptoms in pets, leading to delayed diagnosis and treatment. Veterinary professionals face challenges in accurately diagnosing osteoarthritis due to overlapping symptoms with other conditions. This complexity can result in misdiagnosis or underdiagnosis. Furthermore, limited insurance coverage for companion animals restricts access to advanced therapies. Pet owners often bear the full cost, which can be prohibitive. Lastly, regulatory hurdles in approving new treatments can delay market entry, stifling innovation. These factors collectively impede the growth and accessibility of effective osteoarthritis solutions for companion animals.

Key Players:

Vetoquinol, Dechra Pharmaceuticals, Virbac, Elanco Animal Health, Zoetis, Boehringer Ingelheim Animal Health, Ceva Sante Animale, Bayer Animal Health, Merial, Norbrook Laboratories, Orion Pharma, Aratana Therapeutics, Chanelle Pharma, Phibro Animal Health, Animalcare Group

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Companion Animal Osteoarthritis Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Companion Animal Osteoarthritis Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Device
  • 2.10 Key Highlights of the Market, by Component
  • 2.11 Key Highlights of the Market, by Solutions
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Device
  • 3.9 Market Attractiveness Analysis, by Component
  • 3.10 Market Attractiveness Analysis, by Solutions
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Companion Animal Osteoarthritis Market Outlook

  • 4.1 Companion Animal Osteoarthritis Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Companion Animal Osteoarthritis Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Companion Animal Osteoarthritis Market Size

  • 6.1 Companion Animal Osteoarthritis Market Size, by Value
  • 6.2 Companion Animal Osteoarthritis Market Size, by Volume

7: Companion Animal Osteoarthritis Market, by Type

  • 7.1 Market Overview
  • 7.2 Pharmaceuticals
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Biologics
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Nutraceuticals
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Medical Devices
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Therapeutics
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Diagnostics
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Preventive
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Rehabilitative
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Others
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region

8: Companion Animal Osteoarthritis Market, by Product

  • 8.1 Market Overview
  • 8.2 Non-steroidal Anti-inflammatory Drugs (NSAIDs)
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Disease Modifying Osteoarthritis Drugs (DMOADs)
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Analgesics
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Joint Supplements
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Intra-articular Injections
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Topical Treatments
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Others
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region

9: Companion Animal Osteoarthritis Market, by Services

  • 9.1 Market Overview
  • 9.2 Veterinary Clinics
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Animal Hospitals
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Home Care Services
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Telemedicine
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Rehabilitation Centers
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Consultation Services
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Diagnostic Services
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region
  • 9.9 Others
    • 9.9.1 Key Market Trends & Opportunity Analysis
    • 9.9.2 Market Size and Forecast, by Region

10: Companion Animal Osteoarthritis Market, by Technology

  • 10.1 Market Overview
  • 10.2 Gene Therapy
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Stem Cell Therapy
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Regenerative Medicine
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Biotechnology
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Pharmacogenomics
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Nanotechnology
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Others
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region

11: Companion Animal Osteoarthritis Market, by Application

  • 11.1 Market Overview
  • 11.2 Pain Management
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Inflammation Reduction
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Cartilage Repair
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Mobility Improvement
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Quality of Life Enhancement
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Others
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region

12: Companion Animal Osteoarthritis Market, by End User

  • 12.1 Market Overview
  • 12.2 Veterinary Professionals
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Pet Owners
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Research Institutions
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Pharmaceutical Companies
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Academic Institutes
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Companion Animal Osteoarthritis Market, by Device

  • 13.1 Market Overview
  • 13.2 Orthopedic Implants
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Prosthetics
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Mobility Aids
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Wearable Devices
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Monitoring Devices
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Others
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region

14: Companion Animal Osteoarthritis Market, by Component

  • 14.1 Market Overview
  • 14.2 Active Pharmaceutical Ingredients
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Excipients
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Biologic Components
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Nutraceutical Ingredients
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Device Components
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region
  • 14.7 Others
    • 14.7.1 Key Market Trends & Opportunity Analysis
    • 14.7.2 Market Size and Forecast, by Region

15: Companion Animal Osteoarthritis Market, by Solutions

  • 15.1 Market Overview
  • 15.2 Integrated Care Solutions
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 Personalized Medicine Solutions
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Data Analytics Solutions
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region
  • 15.5 Others
    • 15.5.1 Key Market Trends & Opportunity Analysis
    • 15.5.2 Market Size and Forecast, by Region

16: Companion Animal Osteoarthritis Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Application
    • 16.2.7 North America Market Size and Forecast, by End User
    • 16.2.8 North America Market Size and Forecast, by Device
    • 16.2.9 North America Market Size and Forecast, by Component
    • 16.2.10 North America Market Size and Forecast, by Solutions
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Application
      • 16.2.9.6 United States Market Size and Forecast, by End User
      • 16.2.9.7 United States Market Size and Forecast, by Device
      • 16.2.9.8 United States Market Size and Forecast, by Component
      • 16.2.9.9 United States Market Size and Forecast, by Solutions
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Application
      • 16.2.10.6 Canada Market Size and Forecast, by End User
      • 16.2.10.7 Canada Market Size and Forecast, by Device
      • 16.2.10.8 Canada Market Size and Forecast, by Component
      • 16.2.10.9 Canada Market Size and Forecast, by Solutions
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Application
    • 16.3.7 Europe Market Size and Forecast, by End User
    • 16.3.8 Europe Market Size and Forecast, by Device
    • 16.3.9 Europe Market Size and Forecast, by Component
    • 16.3.10 Europe Market Size and Forecast, by Solutions
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.7 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Solutions
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Application
      • 16.3.10.6 Germany Market Size and Forecast, by End User
      • 16.3.10.7 Germany Market Size and Forecast, by Device
      • 16.3.10.8 Germany Market Size and Forecast, by Component
      • 16.3.10.9 Germany Market Size and Forecast, by Solutions
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Application
      • 16.3.11.6 France Market Size and Forecast, by End User
      • 16.3.11.7 France Market Size and Forecast, by Device
      • 16.3.11.8 France Market Size and Forecast, by Component
      • 16.3.11.9 France Market Size and Forecast, by Solutions
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Application
      • 16.3.12.6 Spain Market Size and Forecast, by End User
      • 16.3.12.7 Spain Market Size and Forecast, by Device
      • 16.3.12.8 Spain Market Size and Forecast, by Component
      • 16.3.12.9 Spain Market Size and Forecast, by Solutions
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Application
      • 16.3.13.6 Italy Market Size and Forecast, by End User
      • 16.3.13.7 Italy Market Size and Forecast, by Device
      • 16.3.13.8 Italy Market Size and Forecast, by Component
      • 16.3.13.9 Italy Market Size and Forecast, by Solutions
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Application
      • 16.3.14.6 Netherlands Market Size and Forecast, by End User
      • 16.3.14.7 Netherlands Market Size and Forecast, by Device
      • 16.3.14.8 Netherlands Market Size and Forecast, by Component
      • 16.3.14.9 Netherlands Market Size and Forecast, by Solutions
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Application
      • 16.3.15.6 Sweden Market Size and Forecast, by End User
      • 16.3.15.7 Sweden Market Size and Forecast, by Device
      • 16.3.15.8 Sweden Market Size and Forecast, by Component
      • 16.3.15.9 Sweden Market Size and Forecast, by Solutions
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Application
      • 16.3.16.6 Switzerland Market Size and Forecast, by End User
      • 16.3.16.7 Switzerland Market Size and Forecast, by Device
      • 16.3.16.8 Switzerland Market Size and Forecast, by Component
      • 16.3.16.9 Switzerland Market Size and Forecast, by Solutions
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Application
      • 16.3.17.6 Denmark Market Size and Forecast, by End User
      • 16.3.17.7 Denmark Market Size and Forecast, by Device
      • 16.3.17.8 Denmark Market Size and Forecast, by Component
      • 16.3.17.9 Denmark Market Size and Forecast, by Solutions
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Application
      • 16.3.18.6 Finland Market Size and Forecast, by End User
      • 16.3.18.7 Finland Market Size and Forecast, by Device
      • 16.3.18.8 Finland Market Size and Forecast, by Component
      • 16.3.18.9 Finland Market Size and Forecast, by Solutions
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Application
      • 16.3.19.6 Russia Market Size and Forecast, by End User
      • 16.3.19.7 Russia Market Size and Forecast, by Device
      • 16.3.19.8 Russia Market Size and Forecast, by Component
      • 16.3.19.9 Russia Market Size and Forecast, by Solutions
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Solutions
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.8 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Solutions
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Application
      • 16.4.9.6 China Market Size and Forecast, by End User
      • 16.4.9.7 China Market Size and Forecast, by Device
      • 16.4.9.8 China Market Size and Forecast, by Component
      • 16.4.9.9 China Market Size and Forecast, by Solutions
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Application
      • 16.4.10.6 India Market Size and Forecast, by End User
      • 16.4.10.7 India Market Size and Forecast, by Device
      • 16.4.10.8 India Market Size and Forecast, by Component
      • 16.4.10.9 India Market Size and Forecast, by Solutions
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Application
      • 16.4.11.6 Japan Market Size and Forecast, by End User
      • 16.4.11.7 Japan Market Size and Forecast, by Device
      • 16.4.11.8 Japan Market Size and Forecast, by Component
      • 16.4.11.9 Japan Market Size and Forecast, by Solutions
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Application
      • 16.4.12.6 South Korea Market Size and Forecast, by End User
      • 16.4.12.7 South Korea Market Size and Forecast, by Device
      • 16.4.12.8 South Korea Market Size and Forecast, by Component
      • 16.4.12.9 South Korea Market Size and Forecast, by Solutions
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Application
      • 16.4.13.6 Australia Market Size and Forecast, by End User
      • 16.4.13.7 Australia Market Size and Forecast, by Device
      • 16.4.13.8 Australia Market Size and Forecast, by Component
      • 16.4.13.9 Australia Market Size and Forecast, by Solutions
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Application
      • 16.4.14.6 Singapore Market Size and Forecast, by End User
      • 16.4.14.7 Singapore Market Size and Forecast, by Device
      • 16.4.14.8 Singapore Market Size and Forecast, by Component
      • 16.4.14.9 Singapore Market Size and Forecast, by Solutions
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Application
      • 16.4.15.6 Indonesia Market Size and Forecast, by End User
      • 16.4.15.7 Indonesia Market Size and Forecast, by Device
      • 16.4.15.8 Indonesia Market Size and Forecast, by Component
      • 16.4.15.9 Indonesia Market Size and Forecast, by Solutions
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Application
      • 16.4.16.6 Taiwan Market Size and Forecast, by End User
      • 16.4.16.7 Taiwan Market Size and Forecast, by Device
      • 16.4.16.8 Taiwan Market Size and Forecast, by Component
      • 16.4.16.9 Taiwan Market Size and Forecast, by Solutions
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Application
      • 16.4.17.6 Malaysia Market Size and Forecast, by End User
      • 16.4.17.7 Malaysia Market Size and Forecast, by Device
      • 16.4.17.8 Malaysia Market Size and Forecast, by Component
      • 16.4.17.9 Malaysia Market Size and Forecast, by Solutions
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Solutions
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Application
    • 16.5.7 Latin America Market Size and Forecast, by End User
    • 16.5.8 Latin America Market Size and Forecast, by Device
    • 16.5.9 Latin America Market Size and Forecast, by Component
    • 16.5.10 Latin America Market Size and Forecast, by Solutions
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Application
      • 16.5.9.6 Brazil Market Size and Forecast, by End User
      • 16.5.9.7 Brazil Market Size and Forecast, by Device
      • 16.5.9.8 Brazil Market Size and Forecast, by Component
      • 16.5.9.9 Brazil Market Size and Forecast, by Solutions
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Application
      • 16.5.10.6 Mexico Market Size and Forecast, by End User
      • 16.5.10.7 Mexico Market Size and Forecast, by Device
      • 16.5.10.8 Mexico Market Size and Forecast, by Component
      • 16.5.10.9 Mexico Market Size and Forecast, by Solutions
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Application
      • 16.5.11.6 Argentina Market Size and Forecast, by End User
      • 16.5.11.7 Argentina Market Size and Forecast, by Device
      • 16.5.11.8 Argentina Market Size and Forecast, by Component
      • 16.5.11.9 Argentina Market Size and Forecast, by Solutions
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Solutions
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.8 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Solutions
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Solutions
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Application
      • 16.6.10.6 UAE Market Size and Forecast, by End User
      • 16.6.10.7 UAE Market Size and Forecast, by Device
      • 16.6.10.8 UAE Market Size and Forecast, by Component
      • 16.6.10.9 UAE Market Size and Forecast, by Solutions
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Application
      • 16.6.11.6 South Africa Market Size and Forecast, by End User
      • 16.6.11.7 South Africa Market Size and Forecast, by Device
      • 16.6.11.8 South Africa Market Size and Forecast, by Component
      • 16.6.11.9 South Africa Market Size and Forecast, by Solutions
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Solutions
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Vetoquinol
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Dechra Pharmaceuticals
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Virbac
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 Elanco Animal Health
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Zoetis
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Boehringer Ingelheim Animal Health
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Ceva Sante Animale
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Bayer Animal Health
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Merial
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Norbrook Laboratories
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Orion Pharma
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Aratana Therapeutics
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 Chanelle Pharma
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 Phibro Animal Health
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Animalcare Group
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제